DexCom Inc (DXCM)
68.99
-0.71
(-1.02%)
USD |
NASDAQ |
Nov 05, 16:00
69.01
+0.02
(+0.03%)
After-Hours: 20:00
DexCom Profit Margin (Quarterly): 13.54% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 13.54% |
| June 30, 2024 | 14.29% |
| March 31, 2024 | 15.90% |
| December 31, 2023 | 24.78% |
| September 30, 2023 | 12.38% |
| June 30, 2023 | 13.30% |
| March 31, 2023 | 6.55% |
| December 31, 2022 | 11.26% |
| September 30, 2022 | 13.15% |
| June 30, 2022 | 7.31% |
| March 31, 2022 | 15.47% |
| December 31, 2021 | -0.76% |
| September 30, 2021 | 13.43% |
| June 30, 2021 | 13.17% |
| March 31, 2021 | 11.19% |
| December 31, 2020 | 62.44% |
| September 30, 2020 | 14.41% |
| June 30, 2020 | 10.25% |
| March 31, 2020 | 4.91% |
| December 31, 2019 | 20.03% |
| September 30, 2019 | 11.56% |
| June 30, 2019 | -3.12% |
| March 31, 2019 | -9.59% |
| December 31, 2018 | -53.17% |
| September 30, 2018 | 17.47% |
| Date | Value |
|---|---|
| June 30, 2018 | 12.45% |
| March 31, 2018 | -13.12% |
| December 31, 2017 | -4.25% |
| September 30, 2017 | -1.08% |
| June 30, 2017 | 1.70% |
| March 31, 2017 | -29.30% |
| December 31, 2016 | -4.32% |
| September 30, 2016 | -12.65% |
| June 30, 2016 | -14.71% |
| March 31, 2016 | -16.52% |
| December 31, 2015 | 1.15% |
| September 30, 2015 | -40.40% |
| June 30, 2015 | -3.97% |
| March 31, 2015 | -17.72% |
| December 31, 2014 | 1.54% |
| September 30, 2014 | -7.54% |
| June 30, 2014 | -10.20% |
| March 31, 2014 | -26.54% |
| December 31, 2013 | -5.03% |
| September 30, 2013 | -13.99% |
| June 30, 2013 | -28.21% |
| March 31, 2013 | -37.50% |
| December 31, 2012 | -25.53% |
| September 30, 2012 | -74.89% |
| June 30, 2012 | -62.82% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-0.76%
Minimum
Dec 2021
62.44%
Maximum
Dec 2020
14.85%
Average
13.24%
Median
Profit Margin (Quarterly) Benchmarks
| Orthofix Medical Inc | -16.84% |
| Abbott Laboratories | 15.48% |
| Bristol-Myers Squibb Co | 10.18% |
| Edwards Lifesciences Corp | 26.43% |
| Tandem Diabetes Care Inc | -13.89% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.96% |
| Return on Assets | 10.48% |
| Return on Invested Capital | 14.61% |
| Gross Profit Margin (Quarterly) | 59.73% |
| Operating Margin (Quarterly) | 15.29% |
| Return on Net Operating Assets | 22.74% |